Details for New Drug Application (NDA): 017352
✉ Email this page to a colleague
NDA 017352 describes FASTIN, which is a drug marketed by Glaxosmithkline and is included in one NDA. Additional details are available on the FASTIN profile page.
The generic ingredient in FASTIN is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
The generic ingredient in FASTIN is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
Summary for 017352
| Tradename: | FASTIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | phentermine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
